AKT1 and type 2 diabetes mellitus: Therefore, the alteration in the miRNA landscape by FhHDM-1, resultant activation of the PI3K/Akt pathway, and preservation of functional β-cell mass open therapeutic avenues for the prevention of T1D and T2D and treatment by enhancing islet transplantation outcomes.